Kary Eldred - Net Worth and Insider Trading
Kary Eldred Net Worth
The estimated net worth of Kary Eldred is at least $157,904 dollars as of 2024-12-01. Kary Eldred is the Director of Galectin Therapeutics Inc and owns about 54,638 shares of Galectin Therapeutics Inc (GALT) stock worth over $157,904. Details can be seen in Kary Eldred's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kary Eldred has not made any transactions after 2024-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kary Eldred
Kary Eldred Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kary Eldred owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Kary Eldred’s form 4 insider trades.
Insider Ownership Summary of Kary Eldred
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-10-23 | director |
Kary Eldred Latest Holdings Summary
Kary Eldred currently owns a total of 1 stock. Kary Eldred owns 54,638 shares of Galectin Therapeutics Inc (GALT) as of October 23, 2024, with a value of $157,904.
Latest Holdings of Kary Eldred
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-10-23 | 54,638 | 2.89 | 157,904 |
Holding Weightings of Kary Eldred
Kary Eldred Form 4 Trading Tracker
According to the SEC Form 4 filings, Kary Eldred has made a total of 6 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 500 shares on October 23, 2024, which cost Kary Eldred around $1,300.
Insider Trading History of Kary Eldred
- 1
Kary Eldred Trading Performance
GuruFocus tracks the stock performance after each of Kary Eldred's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kary Eldred is 29.06%. GuruFocus also compares Kary Eldred's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kary Eldred within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kary Eldred's insider trading performs compared to the benchmark.
Performance of Kary Eldred
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.88 | | | | | |
| Relative Return to S&P 500(%) | 0.85 | | | | | |
Kary Eldred Ownership Network
Kary Eldred Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Kary Eldred is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Kary Eldred made 5 insider transaction in Galectin Therapeutics Inc (GALT) with a net purchase of 3,398. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 16,300 shares made by Kevin D Freeman , a net purchase of 4,500 shares made by Zordani Richard A. Jr. , and a net sale of 25,000 shares made by James C Czirr .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 11,800 shares, with a net purchase of 11,800 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Kary Eldred Mailing Address
Above is the net worth, insider trading, and ownership report for Kary Eldred. You might contact Kary Eldred via mailing address: 2121 Ringwood Avenue, San Jose Ca 95131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
